Bio-Rad Laboratories (BIO-B) Invested Capital (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Invested Capital data on file, last reported at $8.1 billion in Q1 2026.

• Invested Capital for Q1 2026 came in at $8.1 billion, up 2.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.1 billion (up 2.33% YoY), and the FY2025 annual result was $8.7 billion, up 11.41% from the prior year.
• Invested Capital eased to $8.1 billion in Q1 2026 per BIO-B's latest filing, from $8.7 billion in the prior quarter.
• Over five years, Invested Capital peaked at $11.0 billion in Q1 2023 and troughed at $7.1 billion in Q2 2025.
• A 5-year average of $9.0 billion and a median of $9.1 billion in 2024 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2022 and 2025: Invested Capital slumped 36.97% in 2022, then rose 11.41% in 2025.
• A 5-year view of Invested Capital shows it stood at $10.8 billion in 2022, then dropped by 8.07% to $9.9 billion in 2023, then dropped by 21.76% to $7.8 billion in 2024, then climbed by 11.41% to $8.7 billion in 2025, then fell by 6.95% to $8.1 billion in 2026.
• Business Quant data shows BIO-B's Invested Capital at $8.1 billion in Q1 2026, $8.7 billion in Q4 2025, and $7.9 billion in Q3 2025.